Steven Hyman - 25 Jul 2022 Form 4/A - Amendment Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Issuer symbol
CYCN
Transactions as of
25 Jul 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
27 Jul 2022, 16:40:43 UTC
Date Of Original Report
26 Jul 2022
Previous filing
08 Jun 2022
Next filing
07 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Stock Option (Right to Buy) Award $0 +57,753 $0.000000 57,753 25 Jul 2022 Common Stock 57,753 $0.7800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted pursuant to the director compensation plan. 17,753 options will vest in full on the first anniversary of the grant date and 40,000 options will vest monthly pro rata over 36 months starting on the grant date.

Remarks:

This amended Form 4 is being filed solely to correct the vesting periods of the options.